UniProt ID | PALM_HUMAN | |
---|---|---|
UniProt AC | O75781 | |
Protein Name | Paralemmin-1 | |
Gene Name | PALM | |
Organism | Homo sapiens (Human). | |
Sequence Length | 387 | |
Subcellular Localization |
Cell membrane Lipid-anchor Cytoplasmic side . Cell projection, filopodium membrane Lipid-anchor . Cell projection, axon. Cell projection, dendrite. Cell projection, dendritic spine. Basolateral cell membrane Lipid-anchor. Apicolateral cell membrane |
|
Protein Description | Involved in plasma membrane dynamics and cell process formation. Isoform 1 and isoform 2 are necessary for axonal and dendritic filopodia induction, for dendritic spine maturation and synapse formation in a palmitoylation-dependent manner.. | |
Protein Sequence | MEVLAAETTSQQERLQAIAEKRKRQAEIENKRRQLEDERRQLQHLKSKALRERWLLEGTPSSASEGDEDLRRQMQDDEQKTRLLEDSVSRLEKEIEVLERGDSAPATAKENAAAPSPVRAPAPSPAKEERKTEVVMNSQQTPVGTPKDKRVSNTPLRTVDGSPMMKAAMYSVEITVEKDKVTGETRVLSSTTLLPRQPLPLGIKVYEDETKVVHAVDGTAENGIHPLSSSEVDELIHKADEVTLSEAGSTAGAAETRGAVEGAARTTPSRREITGVQAQPGEATSGPPGIQPGQEPPVTMIFMGYQNVEDEAETKKVLGLQDTITAELVVIEDAAEPKEPAPPNGSAAEPPTEAASREENQAGPEATTSDPQDLDMKKHRCKCCSIM | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEVLAAET -------CCCCCCCC | 7.88 | 22223895 | |
8 | Phosphorylation | MEVLAAETTSQQERL CCCCCCCCCCHHHHH | 27.33 | 28857561 | |
9 | Phosphorylation | EVLAAETTSQQERLQ CCCCCCCCCHHHHHH | 18.95 | 28857561 | |
10 | Phosphorylation | VLAAETTSQQERLQA CCCCCCCCHHHHHHH | 36.97 | 28857561 | |
59 | Phosphorylation | ERWLLEGTPSSASEG HHHHHCCCCCCCCCC | 15.60 | 18669648 | |
61 | Phosphorylation | WLLEGTPSSASEGDE HHHCCCCCCCCCCCH | 38.07 | 28555341 | |
62 | Phosphorylation | LLEGTPSSASEGDED HHCCCCCCCCCCCHH | 36.70 | 30576142 | |
64 | Phosphorylation | EGTPSSASEGDEDLR CCCCCCCCCCCHHHH | 44.02 | 27251275 | |
93 | Ubiquitination | DSVSRLEKEIEVLER HHHHHHHHHHHHHHC | 69.45 | - | |
103 | Phosphorylation | EVLERGDSAPATAKE HHHHCCCCCCCHHHH | 38.69 | 24732914 | |
107 | Phosphorylation | RGDSAPATAKENAAA CCCCCCCHHHHHCCC | 36.88 | 24732914 | |
116 | Phosphorylation | KENAAAPSPVRAPAP HHHCCCCCCCCCCCC | 31.16 | 29255136 | |
124 | Phosphorylation | PVRAPAPSPAKEERK CCCCCCCCCCCHHHC | 39.33 | 25159151 | |
132 | Phosphorylation | PAKEERKTEVVMNSQ CCCHHHCCEEEECCC | 39.99 | 24732914 | |
138 | Phosphorylation | KTEVVMNSQQTPVGT CCEEEECCCCCCCCC | 12.93 | 21955146 | |
141 | Phosphorylation | VVMNSQQTPVGTPKD EEECCCCCCCCCCCC | 16.59 | 22167270 | |
145 | Phosphorylation | SQQTPVGTPKDKRVS CCCCCCCCCCCCCCC | 27.65 | 22167270 | |
152 | Phosphorylation | TPKDKRVSNTPLRTV CCCCCCCCCCCCEEE | 38.73 | 30266825 | |
154 | Phosphorylation | KDKRVSNTPLRTVDG CCCCCCCCCCEEECC | 19.05 | 30266825 | |
158 | Phosphorylation | VSNTPLRTVDGSPMM CCCCCCEEECCCHHH | 30.54 | 23403867 | |
162 | Phosphorylation | PLRTVDGSPMMKAAM CCEEECCCHHHHHEE | 12.73 | 19664994 | |
162 (in isoform 2) | Phosphorylation | - | 12.73 | 19664994 | |
170 | Phosphorylation | PMMKAAMYSVEITVE HHHHHEEEEEEEEEE | 12.58 | 27642862 | |
171 | Phosphorylation | MMKAAMYSVEITVEK HHHHEEEEEEEEEEE | 10.53 | 28348404 | |
189 | Phosphorylation | TGETRVLSSTTLLPR CCCEEEEEECCCCCC | 23.84 | 28857561 | |
190 | Phosphorylation | GETRVLSSTTLLPRQ CCEEEEEECCCCCCC | 22.65 | 28857561 | |
191 | Phosphorylation | ETRVLSSTTLLPRQP CEEEEEECCCCCCCC | 20.35 | 28857561 | |
192 | Phosphorylation | TRVLSSTTLLPRQPL EEEEEECCCCCCCCC | 28.39 | 28509920 | |
201 (in isoform 2) | Phosphorylation | - | 17.03 | 25921289 | |
205 (in isoform 2) | Phosphorylation | - | 6.30 | 25921289 | |
206 | Phosphorylation | LPLGIKVYEDETKVV CCCCEEEEECCCEEE | 16.80 | 23532336 | |
243 | Phosphorylation | IHKADEVTLSEAGST HHHCCEEEHHHCCCC | 23.63 | - | |
245 | Phosphorylation | KADEVTLSEAGSTAG HCCEEEHHHCCCCCC | 18.94 | 30266825 | |
249 | Phosphorylation | VTLSEAGSTAGAAET EEHHHCCCCCCHHHH | 23.33 | 30266825 | |
250 | Phosphorylation | TLSEAGSTAGAAETR EHHHCCCCCCHHHHH | 28.35 | 28857561 | |
256 | Phosphorylation | STAGAAETRGAVEGA CCCCHHHHHHCCCCC | 29.67 | 30266825 | |
305 | Phosphorylation | VTMIFMGYQNVEDEA EEEEEECCCCCCCHH | 5.78 | 25884760 | |
333 (in isoform 2) | Ubiquitination | - | 39.70 | 21906983 | |
346 | Phosphorylation | EPAPPNGSAAEPPTE CCCCCCCCCCCCCCH | 30.83 | 15345747 | |
352 | Phosphorylation | GSAAEPPTEAASREE CCCCCCCCHHHCHHH | 49.31 | 30266825 | |
356 | Phosphorylation | EPPTEAASREENQAG CCCCHHHCHHHHCCC | 47.47 | 30266825 | |
367 | Phosphorylation | NQAGPEATTSDPQDL HCCCCCCCCCCHHHH | 25.77 | 15345747 | |
368 | Phosphorylation | QAGPEATTSDPQDLD CCCCCCCCCCHHHHC | 37.87 | 27732954 | |
369 | Phosphorylation | AGPEATTSDPQDLDM CCCCCCCCCHHHHCH | 42.83 | 15345747 | |
377 | Ubiquitination | DPQDLDMKKHRCKCC CHHHHCHHHHCCCCC | 45.13 | 2190698 | |
377 (in isoform 1) | Ubiquitination | - | 45.13 | 21906983 | |
381 | S-palmitoylation | LDMKKHRCKCCSIM- HCHHHHCCCCCCCC- | 3.85 | - | |
383 | S-palmitoylation | MKKHRCKCCSIM--- HHHHCCCCCCCC--- | 2.23 | - | |
384 | Methylation | KKHRCKCCSIM---- HHHCCCCCCCC---- | 1.56 | - | |
384 | Farnesylation | KKHRCKCCSIM---- HHHCCCCCCCC---- | 1.56 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PALM_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PALM_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PALM_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of PALM_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-124; THR-141 ANDTHR-145, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-116; SER-124; THR-141;THR-145; THR-154 AND SER-162, AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-141 AND THR-145, ANDMASS SPECTROMETRY. |